AIEU-Startupsabout 2 hours ago
Telum Therapeutics raises €18M for infection treatments
3 min read
Telum Therapeutics closed an €18 million Series A financing. AMR Action Fund led the round with participation from Inveready and existing investors. The funds advance a lead program targeting hospital-acquired and ventilator-associated bacterial pneumonia.
Level
Hype check
Tap to vote and see what everyone thinks.
